Decreased β2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: Analysis by reverse transcription-polymerase chain reaction

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1065-1069

  Takahashi, H ^a   Kinouchi, M ^a   Tamura, T ^a   Iizuka, H ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; INVOLUCRIN; LORICRIN; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PSORIASIS;

ACTINS; ADULT; BASE SEQUENCE; EPIDERMIS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; PSORIASIS; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER;

EID: 0030002576     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07944.x     Document Type: Article

References (33)

1. Hsia SL, Wright R, Mandy SH, Halprin KM. Adenyl cyclase in normal and psoriatic skin. J Invest Dermatol 1972; 59: 109-13.
2. Iizuka H, Adachi K, Halprin KM, Levine V. Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and epinephrine by the uninvolved and involved epidermis. J Invest Dermatol 1978; 70: 250-3.
3. Gommans JM, Bergers M, van Erp PEJ, et al. Studies on the plasma membrane of normal and psoriatic keratinocytes. Br J Dermatol 1979; 101: 413-19.
4. Voorhees JJ. Commentary: cyclic adenosine monophosphate regulation of normal and psoriatic epidermis. Arch Dermatol 1982; 118: 869-74.
5. Dover R, Watt FM. Measurement of the rate of epidermal terminal differentiation: expression of involuerin by S-phase keratinocytes in culture and psoriasis plagues. J Invest Dermatol 1987; 89: 349-52.
6. Bernard BA, Asselineau D, Schaffar-Deshayes L, Darmon MY. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol 1988; 90: 801-5.
7. Juhlin L, Magnaldo T, Darmon M. Expression of loricrin in skin disorders. Acta Derm Venereol (Stockh) 1992; 72: 407-9.
8. Hohl D. Expression patterns of loricrin in dermatological disorders. Am J Dermatopathol 1993; 15: 20-7.
9. Ishida-Yamamoto A, Iizuka H. Differences in involucrin immuno-labeling within cornified cell envelopes in normal and psoriatic epidermis. J Invest Dermatol 1995; 104: 391-5.
10. Mansbridge JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987; 89: 253-63.
11. Iizuka H, Matsuo S, Tamura T, Ohkuma N. Increased cholera toxin-, and forskolin-induced cyclic AMP accumulations in psoriatic involved versus uninvolved or normal human epidermis. J Invest Dermatol 1988; 91: 154-7.
12. Iizuka H, Sakai H, Tamura T. Effect of tumor promoter, phorbol 12-myristate, 13-acetate, on the epidermal adenylate cyclase system: evidence for adenylate cyclase-regulation by protein kinase C. J Invest Dermatol 1989; 93: 387-91.
13. Itami S, Kino J, Halprin KM, Adachi K. Immunohistochemical study of beta-adrenergic receptors in the psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody. Arch Dermatol Res 1987; 279: 439-46.
14. Steinkraus V, Steinfath M, Stoeve L et al. 3-Adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin. Arch Dermatol Res 1993; 285: 300-4.
15. Leigh IM, Pulford KA, Ramackers FCS, Lane EB. Psoriasis: maintenance of an intact monolayer nasal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol 1985; 113: 53-64.
16. Bernerd F, Magnaldo T, Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992; 98: 902-10.
17. Hohl D, Roop D, Loricrin. In: Molecular Biology of the Skin. The Keratinocytes (Darmon M. Blumenberg M. eds). San Diego: Academic Press, 1993; 151-79.
18. Eckert RL, Yaffe MB, Crish JF et al. Involucrin - structure and role in envelope assembly. J Invest Dermatol 1993; 100: 613-17.
19. Steinert PM. A model for the hierarchical structure of the human epidermal cornified cell envelope. Cell Death Differentiation 1995; 2: 33-40.
20. Maniatis T, Fritsch EF, Sambrook T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory, 1989.
21. Takahashi H, Miyokawa N, Katagiri M, Iizuka H. Expression of guanine nucleotide binding proteins, Gs and Gi, in mRNA in epidermal keratinocytes. Arch Dermatol Res 1990; 282: 392-6.
22. 2 adrenergic receptor. Proc Natl Acad Sci USA 1987; 84: 46-50.
23. Yoneda K, Hohl D, McBride OW et al. The human loricrin gene. J Biol Chem 1992; 267: 18060-6.
24. Eckert RL, Green H. Structure and evolution of the human involucrin gene. Cell 1986; 46: 583-9.
25. Ponte P, Ng SY, Engel J et al. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687-96.
26. Makino R, Sekiya T, Hayashi K. Evaluation of quantitative detection of mRNA by the reverse transcription-polymerase chain reaction. Technique 1990; 2: 295-301.
27. 2-adrenergic receptors. J Biol Chem 1986; 261: 14562-70.
28. Fisher GJ, Tarwar HS. Baldassare JJ et al. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4.5-bisphosphate and 1.2-sn-diacylglycerol component in psoriatic involved compared to uninvolved and normal epidermis. J Invest Dermatol 1990; 95: 428-35.
29. Iizuka H, Takahashi H. Psoriasis, involucrin and protein kinase C. Int J Dermatol 1993; 32: 333-8.
30. Rasmussen HH, Celis JE. Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. J Invest Dermatol 1993;101: 560-6.
31. Younus J, Gilchrest BA. Modulation of mRNA levels during human keratinocyte differentiation. J Cell Physiol 1992; 152: 232-9.
32. Takahashi H, Iizuka H. Analysis of the 5′-upstream of human involucrin gene: activation by 12-o-tetradecanoylphorbol-13-acetate. J Invest Dermatol 1993; 100: 10-5.
33. DiSepio D, Jones A, Longley MA et al. The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specitic but not differentiation-specific expression. J Biol Chem 1995; 270: 10792-9.